about
Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancerCorrelations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer.Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical CancerFoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinomaThe tumor area occupied by Tbet+ cells in deeply invading cervical cancer predicts clinical outcome.Role of IL-12p40 in cervical carcinoma.Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequencyPrognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples.The correlations between IL-17 vs. Th17 cells and cancer patient survival: a systematic review.A high IL6/IL17 ratio combined with low IL5 expression is correlated with poor survival in squamous cervical cancer.Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
P50
Q35201856-84ECF881-5106-454A-9F12-B6395AC30D59Q35357735-8144581D-0472-4D4F-8217-1874E1E7AFC5Q35661292-F746C966-47DF-431C-A2F5-67B747080272Q35687003-9ED6C633-8096-47F4-8F1E-460EC935664CQ36050315-77BDC70D-F197-4DDA-9376-B16F3381815CQ36451737-A90A2B42-D1D6-4DDB-BAF1-D1D96E8E28F9Q36629387-74B9D312-095A-47E4-A51A-2FFE648EE916Q36783066-14F6EB13-674A-4EEB-932F-C2B7DF7ACCA9Q37061685-F0574D1F-9263-41D1-8CDF-99B7848151C5Q38372482-FE07AB84-E4B2-40D6-9B8C-F0936F870D95Q42600273-18B126A0-F6E6-4AFE-B7BD-D7DCF0D927CAQ46597287-AC8E796C-3419-42D7-BF97-F4F050C1D298Q88301710-90CA4E83-F6B5-48EA-876F-683D29E9F524
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-6675-728X
@en
name
Simone Punt
@ast
Simone Punt
@en
Simone Punt
@es
Simone Punt
@nl
type
label
Simone Punt
@ast
Simone Punt
@en
Simone Punt
@es
Simone Punt
@nl
prefLabel
Simone Punt
@ast
Simone Punt
@en
Simone Punt
@es
Simone Punt
@nl
P106
P31
P496
0000-0002-6675-728X